Advanced search
Publication Cover
Journal of Medical Economics Volume 17, 2014 - Issue 12
Submit an article Journal homepage
1,341
Views
7
CrossRef citations to date
0
Altmetric
Oncology: Original article

Cost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe

Mario CamponeCentre René Gauducheau, Service Oncologie Médicale Nantes Saint-HerblainFrance
,
Hongbo YangAnalysis Group, Inc. Boston, MAUSACorrespondence[email protected]
,
Elizabeth FaustAnalysis Group, Inc. Boston, MAUSA
,
Andrew KageleiryAnalysis Group, Inc. Boston, MAUSA
,
James E. SignorovitchAnalysis Group, Inc. Boston, MAUSA
,
Jie ZhangNovartis Pharmaceuticals Corporation East Hanover, NJUSA
&
Haitao GaoNovartis Pharmaceuticals Corporation East Hanover, NJUSA
 show all
Pages 837-845 | Accepted 26 Aug 2014, Published online: 18 Sep 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

María Presa, David Vicente, Antonio Calles, Laura Salinas-Ortega, Jaesh Naik, Luis F García & Javier Soto. (2023) Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain. ClinicoEconomics and Outcomes Research 15, pages 659-671.
Read now
M. Marchetti & C. Visco. (2023) Cost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma. Leukemia & Lymphoma 64:8, pages 1442-1450.
Read now
Nanxin Li, Yanni Hao, Valerie Koo, Anna Fang, Miranda Peeples, Andrew Kageleiry, Eric Q. Wu & Annie Guérin. (2016) Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2− metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis. Journal of Medical Economics 19:4, pages 414-423.
Read now

Articles from other publishers (4)

Nicolas S. H. Xander, W. Edward Fiets & Carin A. Uyl-de Groot. (2023) Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands. Frontiers in Oncology 13.
Crossref
Jason T. Hurwitz, Shannon Vaffis, Amy J. Grizzle, Søren Nielsen, Andrew Dodson & Suzanne Parry. (2022) Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT). Oncology and Therapy 10:2, pages 391-409.
Crossref
Fatima Cardoso, Nils Wilking, Renato Bernardini, Laura Biganzoli, Jaime Espin, Kaisa Miikkulainen, Susanne Schuurman, Danielle Spence, Sabine Spitz, Sonia Ujupan, Nicole Zernik & Jenn Gordon. (2020) A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments. The Breast 52, pages 78-87.
Crossref
Yan SongYanni HaoAlexander R. MacalaladPeggy L. LinJames E. SignorovitchEric Q. Wu. (2015) Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2-Metastatic Breast Cancer. Breast Cancer: Basic and Clinical Research 9, pages BCBCR.S30771.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.